Endoscopic Surveillance for Patients with Barrett Esophagus: Does the Cancer Risk Justify the Practice?
Authors: STUART JON SPECHLER
Journal: Annals of Internal Medicine (1987)

Editorials1 June 1987Endoscopic Surveillance for Patients with Barrett Esophagus: Does the Cancer Risk Justify the Practice?STUART JON SPECHLER, M.D.STUART JON SPECHLER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-106-6-902 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptBarrett esophagus is a condition that has clinical importance primarily because of its association with adenocarcinoma. Recent studies (1-3) have reported an incidence of esophageal cancer for patients with Barrett esophagus of approximately one case per 200 patientyears, which is approximately 30 to 40 times higher than that in the general population of the United States (4). Cancer of the esophagus is a tumor not commonly found in the general population, however, accounting for only about 1% of all malignancies reported in this country (5). Even a fortyfold increase in the incidence of this uncommon neoplasm represents a small risk...References1. SPECHLERROBBINSRUBINS SAH. Adenocarcinoma and Barrett's esophagus: an overrated risk? Gastroenterology. 1984;87:927-33. CrossrefMedlineGoogle Scholar2. CAMERONOTTPAYNE ABW. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985;313:857-9. CrossrefMedlineGoogle Scholar3. SPRUNGELLISGIBB DFS. Incidence of adenocarcinoma in Barrett's esophagus [Abstract]. Am J Gastroenterol. 1984;79:817. Google Scholar4. SPECHLERGOYAL SR. Barrett's esophagus. N Engl J Med. 1986;315:362-71. CrossrefMedlineGoogle Scholar5. SONDIKYOUNGHORMGLOECKLER EJJL. 1985 Annual Cancer Statistics Review. Bethesda, Maryland: National Cancer Advisory Board; 1985. (DHHS publication no. [NIH] 86-2789). Google Scholar6. WUHUANGSHAOZHANGLIN YGLYX. Honored guest's address: progress in the study and surgical treatment of cancer of the esophagus in China, 1940-1980. J Thorac Cardiovasc Surg. 1982;84:325-33. CrossrefMedlineGoogle Scholar7. ANDERSONLAD LT. Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer. 1982;50:1587-90. CrossrefMedlineGoogle Scholar8. GUANREIHESUNGLIANGYUMING YHQC. Endoscopic diagnosis of 115 cases of early esophageal carcinoma. Endoscopy. 1982;14:157-61. CrossrefMedlineGoogle Scholar9. RIDDELL R. Dysplasia and regression in Barrett's epithelium. In: SPECHLER SJ, GOYAL RK, eds. Barrett's Esophagus: Pathophysiology, Diagnosis and Management. New York: Elsevier Science; 1985:143-52. Google Scholar10. . Guidelines for the cancer-related check-up: recommendations and rationale. CA. 1980;30:194-240. Google Scholar11. EDDY D. The economics of cancer prevention and detection: getting more for less. Cancer. 1981;47(suppl 5):1200-9. CrossrefMedlineGoogle Scholar12. GOYHEROLDJENKINSCOLMANRUSSELL JEPJD. "Open-access" endoscopy for general practitioners: experience of a private gastrointestinal clinic. Med J Aust. 1986;144:71-4. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston Veterans Administration Medical Center Boston University School of Medicine Boston, Massachusetts PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThe effect of reactive atypia/inflammation on the laser-induced fluorescence diagnosis of non-dysplastic Barrett's esophagusTransthoracic esophagectomy vs transhiatal esophagectomy for the surgical treatment of esophageal carcinoma.Gastrointestinal TractThe role of surveillance endoscopy and endosonography after endoscopic ablation of high-grade dysplasia and carcinoma of the esophagusSurveillance in Barrett??s oesophagusBarrett's oesophagusEUS in the Management of the Patient With Dysplasia in Barrett's EsophagusCharacteristics of patients with columnar-lined Barrett’s esophagus and risk factors for progression to esophageal adenocarcinomaEffect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancerTransthoracic esophagectomy vs transhiatal esophagectomy for the surgical treatment of esophageal carcinoma.Unsedated transnasal endoscopy accurately detects Barrett's metaplasia and dysplasiaDysplasia in Barrett's esophagusEsophageal CancerScreening and surveillance for complications related to gastroesophageal reflux diseaseDisputing dysplasiaAdvantages and disadvantages of population screening for cancer and surveillance of at-risk groupsThe pathology of epithelial pre-malignancy of the gastrointestinal tractBarrett's oesophagus: diagnosis and managementEndoscopic ultrasound in Barrett's esophagusIntestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardiaSafety of A Systematic Endoscopic Biopsy Protocol in Patients With Barrett's EsophagusProspective Multivariate Analysis of Clinical, Endoscopic, and Histological Factors Predictive of The Development of Barrett's Multifocal High-Grade Dysplasia or AdenocarcinomaRegression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methodsA Cost Analysis of Outpatient Care for Patients With Barrett's Esophagus in A Managed Care SettingBarrett's Esophagus: A New Look at Surveillance Based on Emerging Estimates of Cancer RiskEvolution of neoplastic cell lineages in Barrett oesophagusThe role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tractCLINICAL MODELS OF CHEMOPREVENTION FOR THE ESOPHAGUSSurveillance in Barrett's oesophagus: A need for reassessment?Extended AbstractsENDOSONOGRAPHY IN COLUMNAR-LINED ESOPHAGUSSURGICAL TREATMENT OF DYSPLASIA AND ADENOCARCINOMAEsophageal carcinoma: Current controversiesPrognostic Factors in Esophageal CancerNeoplastic Progression in Barrett’s EsophagusEsophageal Columnar Metaplasia (Barrett’s Esophagus)Contributions of the Molecular Biologist in Gastrointestinal Cancer and Precancer Screening: Current Possibilities and Future ProspectsChanging patterns and surgical results in adenocarcinoma of the oesophagusc-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.Expansion of the Ki-67 proliferative compartment correlates with degree of Dysplasia in Barrett's esophagusAssociation of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variablesMétaplasie cylindrique œsophagienne (MCO) et risque d’adénocarcinomeBiopsy of Upper Gastrointestinal Tract LesionsOutcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patientsBarrett's esophagus, dysplasia, and adenocarcinomaBarrett’s EsophagusBarrett's oesophagus-cancer risk, biology and therapeutic managementAn endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagusLaser photoablation of Barrett's epithelium: Burning issues about burning tissuesLésions malignes en métaplasie cylindrique œsophagienneLaser-induced transient regression of Barrett's epitheliumLength of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma.Endoscopic Assessment of Premalignant Esophageal DisordersEndoscopic Diagnosis of Esophageal NeoplasmsAdenocarcinoma in Barrett's esophagus: A new epidemic?Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohortEvaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometryBarrett's esophagus and adenocarcinoma: From the family to the geneThe neoplastic potential of columnar-lined (Barrett's) esophagusA comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagusBarrett's Esophagus and Esophageal AdenocarcinomaGastrointestinal EndoscopyBarrett Esophagus: A Sequela of ChemotherapyStuart Jon Spechler, MDBarrett's oesophagusBarrett's EsophagusAdenocarcinoma in Barrett's esophagusEndoscopic Screening and Surveillance for Gastrointestinal MalignancyDiscordance between flow cytometric abnormalities and dysplasia in Barrett's esophagusBarrett's Esophagus: Detection and ManagementGastroesophageal reflux diseaseBarrett's Esophagus; Development of Dysplasia and AdenocarcinomaSurgery and current management for cancer of the esophagus and cardiaSurgery and current management for cancer of the esophagus and cardia: Part IIPrevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junctionSurgery and current management for cancer of the esophagus and cardia: Part ISelective therapeutic approach to cancer of the lower esophagus and cardiaEndoscopic Surveillance of Patients with Barrett EsophagusFRANK A. LEDERLE, M.D.Barrett EsophagusROBERT G. NORFLEET, M.D. 1 June 1987Volume 106, Issue 6Page: 902-904KeywordsAdenocarcinomaEsophageal cancerEsophagus Issue Published: 1 June 1987 PDF DownloadLoading ...